Anatara Lifesciences Ltd has released a press release.
Webinar Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
In the deck
Story so far
Earlier from Anatara Lifesciences
- Anatara IBS trial positive secondary endpoint data analysis
- ANR announces Positive Results from Stage 1 of IBS trial
- IBS clinical trial Stage 1 patients finalised
- Appendix 4E & Audited Financial Statements 30 June 2023
- $923,235 in R&D tax incentive received
Later from Anatara Lifesciences
- Appendix 4C & Q1 FY24 Activities Report
- Anatara launches a partially underwritten Entitlement Offer
- Cleansing Notice
- GaRP Clinical Trial AGM Presentation
- AGM Chair Address
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences